Register for free to listen to this article
Listen with Speechify
0:00
1:00
BioTek Instruments Inc.
 
BioTek has launched the Epoch Multi-Volume SpectrophotometerSystem for monochromator based absorbance measurements in volumes as low as 2µL. The system includes the Epoch Microplate Spectrophotometer and the uniqueTake3 Multi-Volume Plate, controlled via Gen5 software. These two new productscombine to provide a high-value solution for the life science laboratory thathas multiple users and assays and the need to preserve precious nucleic acidand protein samples by using very small volumes for quantification. With itswavelength range of 200 nm to 999 nm, the Epoch Microplate Spectrophotometerprovides outstanding performance in nucleic acid and protein quantification,wavelength scanning, end point, kinetic and well area scanning in 6- to384-well microplates. The Take3 plate allows users to measure up to sixteen 2µL samples, two BioCells or a standard cuvette. The Take3 interface in Gen5software makes low-volume nucleic acid quantification fast and easy with itspre-programmed protocols and data output.
 
 
BioTek Instruments Inc.
(888) 451-5171


Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue